KeypointsIn specific patient groups with a bone conduction hearing implant, ie children or patients with compromised bone quality, the incidence of implant loss is much higher; further implant optimisation is, therefore, needed.The new laser‐ablated titanium implant for bone‐anchored hearing implantation has an enlarged contact area for osseointegration compared to the standard implant, aiming to improve implant loss rates.This retrospective multicentre study is the first to assess the performance of this implant in healthy adults 1 year after surgery.With excellent survival rates, good soft tissue tolerability and few complications, the implant is safe to use in healthy adults.INTRODUCTIONSuccessful bone‐anchored hearing implantation requires good osseointegration of the titanium implant in the temporal bone and low skin‐related complication rates. The introduction of wider diameter implants, providing an enlarged bone‐implant interface and thus a larger interface for osseointegration, has resulted in up to 3‐year survival rates of >96% in healthy adult patients. Despite the low incidence of implant loss in healthy adults, in certain patient groups, ie patients with compromised bone quality or in children, the incidence is much higher, varying between 3.5%‐10.5% even with these wider diameter implants. To improve implant survival in these populations as well, further optimisation of implant material,
Clinical Otolaryngology – Wiley
Published: Jan 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud